KAPA
Financials
- Market Capitalization 5.69 M
- Employee 1
- Founded 2013
- CEO N/A
- Website www.kairospharma.com
- Headquarter Delaware, United States
- FIGI BBG01JLR1R85
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4636 |  MDCX Medicus Pharma Ltd. - Common Stock | 0.26 USD | -3.70% | -3.70% | 0.00% | -77.97% | 16.43 M USD | ||
| 4891 |  APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 3.88 USD | -0.51% | -13.78% | -29.07% | +196.18% | 5.86 M USD | ||
| 4966 |  VIVS VivoSim Labs, Inc. - Common Stock | 0.29 USD | 0.00% | +3.57% | -14.71% | -84.82% | 4.31 M USD | ||
| 5018 |  PPCB Propanc Biopharma, Inc. - Common Stock | 1.35 USD | -39.46% | +19.47% | +35.00% | -54.85% | 3.08 M USD |
Frequently asked questions about Kairos Pharma, Ltd.
What is the Kairos Pharma, Ltd. stock price today?
The current price of Kairos Pharma, Ltd. (KAPA) is 0.24. Over the past 24 hours, the stock has changed by 0.00%. Follow the KAPA chart for real-time price dynamics.
What is the stock ticker of Kairos Pharma, Ltd.?
Kairos Pharma, Ltd. trades under the ticker KAPA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Kairos Pharma, Ltd. stock going up?
KAPA has changed by 0.00% over the last week, -17.24% over the last month, and -58.62% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Kairos Pharma, Ltd.?
Kairos Pharma, Ltd. currently has a market capitalization of 5.69 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Kairos Pharma, Ltd. earnings last quarter?
Last quarter, Kairos Pharma, Ltd. reported earnings of -0.06 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Kairos Pharma, Ltd. revenue for the last quarter?
Kairos Pharma, Ltd. reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Kairos Pharma, Ltd. net income for the last quarter?
Kairos Pharma, Ltd. reported net income of -1.39 M for the last quarter. The previous quarter showed -1.65 M, which means net income changed by +16.08%.
How many employees does Kairos Pharma, Ltd. have?
As of the latest available data, Kairos Pharma, Ltd. has 1 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Kairos Pharma, Ltd. stock?
You can buy Kairos Pharma, Ltd. (KAPA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Kairos Pharma, Ltd. stock?
Investing in Kairos Pharma, Ltd. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KAPA chart and related analysis on metatrader.com as part of your research.